Concepedia

Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate

Margarita Salcedo, Nadège Bercovici, Rachel R. Taylor, Séverine Massicard, Dominique Duriau, Frédérique Vernel-Pauillac, Aurélie Boyer, Véronique Baron‐Bodo, Eric Mallard, Jacques Bartholeyns,

Cancer Immunology Immunotherapy · 2005 · 139 citations · 39 references

DOIFull text

Open access

Concepts

References

39

Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

Frank O. Nestlé, Selma Alijagic, Michel Gilliet et al. · Nature Medicine · 1998 · 2.9K citations

, , +14

Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells

Anja Langenkamp, Mara Messi, Antonio Lanzavecchia et al. · Nature Immunology · 2000 · 1.1K citations

, , +14

Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules

Zu T. Shen, G Reznikoff, Glenn Dranoff et al. · The Journal of Immunology · 1997 · 838 citations · Full text

, , +14

Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine.

Jacques Banchereau, A. Karolina Palucka, Madhav V. Dhodapkar et al. · PubMed · 2001 · 813 citations

, , +17

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte–macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

Robert J. Soiffer, Thomas J. Lynch, Martin Mihm et al. · Proceedings of the National Academy of Sciences · 1998 · 579 citations

, , +17